Crimes against Dalits, women high in BJP-ruled States

News Network
May 6, 2018

Hubballi, May 6: Referring to data from the National Crime Records Bureau (NCRB), former Union Home Minister Sushilkumar Shinde said that under BJP’s watch, a Dalit suffered an atrocity every 12 minutes and six Dalit women were raped every day.

Addressing presspersons along with AICC General Secretary Mukul Wasnik and spokesperson Pavan Khera, Mr Shinde said that highest crimes against Adivasis were registered in BJP ruled states of Chhatisgarh and Madhya Pradesh.

States that accounted for a majority of crimes against Dalits as per NCRB, were the BJP-ruled States of Madhya Pradesh (43.4%), Rajasthan (42%), Goa (36.7%) and Gujarat (32.5%), while Congress-ruled Karnataka recorded significantly lesser crimes against Dalits, he said.

Mr. Shinde said the last four years of the NDA rule at the Centre had witnessed an anti-Dalit and anti-adivasi bias like never before, leading to a brazen attack on the Constitution. “And the dilution of Scheduled Castes and Scheduled Tribes (Prevention of Atrocities) Act, 1989, is a consequence of this deep rooted prejudice,” he said.

In contrast to this, the Congress-led government in Karnataka has initiated measures to empower the SC/STs and weaker sections. In fact based on the population, the budgetary allocation had been increased to 24.10% to facilitate their empowerment, he said.

Mr. Wasnik said that there had been massive cuts in allocation to Scheduled Castes in the Central budget. The allocation to SCs which accounted for 16.6% of the country’s population has been now reduced to 5.5%, he said.

He pointed out that even in terms of jobs for SCs there had been a massive reduction of 91%. While there were 92,928 jobs for Dalits in the Central government during the Congress rule (2013), it came down to just 8,436 in 2015 under BJP, he said.

Taking a dig at Prime Minister Narendra Modi, he said while Mr. Modi praised B.R. Amedkar, his party’s goons were vandalising the statues of Ambedkar.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 26,2020

Jun 26: The Supreme Court on Friday permitted the Centre and the CBSE to cancel the remaining board examinations due to the COVID-19 pandemic and gave the go-ahead for the scheme to award marks to students for the cancelled papers scheduled to be held in July.

A bench of Justices A M Khanwilkar, Dinesh Maheshwari and Sanjiv Khanna permitted the CBSE to issue a notification for the cancellation of the examinations.

Solicitor General Tushar Mehta, appearing for the Centre and the CBSE, said that the assessment scheme would consider marks scored by students in the last three papers of the board exams.

Both CBSE and ICSE told the top court that the results of the class X and XII board exams can be declared by the middle of July.

The top court was hearing pleas seeking relief, including scrapping of remaining exams of Class 12 scheduled from July 1 to 15, in view of increasing number of COVID-19 cases. Similar relief was sought by the ICSE Board also.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 4,2020

New Delhi, Feb 4: The investigation into the incident of violence at Jamia Millia Islamia during an anti-citizenship law protest was at a crucial stage, the Centre told the Delhi High Court on Tuesday.

The submission before a bench of Chief Justice D N Patel and Justice C Hari Shankar was made by Solicitor General Tushar Mehta while seeking more time to file a report regarding the probe.

Taking note of the submission, the bench granted the Centre time till April 29 to file a reply.

During the hearing, senior advocate Colin Gonsalves, appearing for some students of Jamia, said 93 students and teachers filed complaints about alleged attacks on them by police but no FIR has been filed against the agency till date.

The other lawyers for the petitioners alleged that the government has not complied with the court order to file a response within four weeks of the last date of hearing on December 19.

The bench, however, declined to pass any interim order and granted time till April 29 to the government to file a reply.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.